Galderma’s Phase III OLYMPIA 1 Data Published in JAMA Dermatology Demonstrate That Nemolizumab Improves Core Signs and Symptoms of Prurigo Nodularis November 29, 2024
UNION therapeutics to present at the 8th Annual Dermatology Drug Development Summit in Boston November 7, 2024
SciBase expands to new market in Pennsylvania and receives first order from large dermatology practice September 26, 2024
